首页> 外文期刊>Cancer: A Journal of the American Cancer Society >A score to identify patients with metastatic spinal cord compression who may be candidates for best supportive care
【24h】

A score to identify patients with metastatic spinal cord compression who may be candidates for best supportive care

机译:识别可能是最佳支持治疗候选人的转移性脊髓压迫患者的评分

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The objective of the current study was to develop a scoring system that identifies those patients with metastatic spinal cord compression who may be candidates for best supportive care or single-fraction radiotherapy. METHODS: Ten potential prognostic factors were retrospectively analyzed in 2029 patients, including age, gender, Eastern Cooperative Oncology Group performance status, tumor type, number of involved vertebrae, further bone metastases, visceral metastases, interval from time of cancer diagnosis to the development of MSCC, time to the development of motor deficits, and ambulatory status. RESULTS: On multivariate analysis, Eastern Cooperative Oncology Group performance status, tumor type, bone metastases, visceral metastases, interval from cancer diagnosis to the development of metastatic spinal cord compression, time to the development of motor deficits, and ambulatory status were found to be significantly associated with survival. The risk score represented the sum of the scores for each of these factors, obtained from the probability of the patient dying within 2 months (shown as the percentage) divided by 10. Risk scores ranged between 6 and 25 points. At a cutoff value of 24 points, the specificity was 99.8% and the positive predictive value was 96.0%, which indicates that approximately 4% of the patients predicted to die within 2 months survived > 2 months. CONCLUSIONS: This score identifies patients who have a very poor survival with a high specificity and a high positive predictive value. Patients with a score of 24 points have a very high probability of dying within 2 months. Thus, overtreatment with intensive therapies can be avoided in these patients, who are very unlikely to benefit.Cancer 2013. (c) 2012 American Cancer Society.
机译:背景:本研究的目的是开发一种评分系统,以识别那些可能是最佳支持治疗或单次放疗候选者的转移性脊髓压迫患者。方法:回顾性分析了2029例患者的十个潜在预后因素,包括年龄,性别,东部合作肿瘤小组的表现状况,肿瘤类型,受累椎骨数量,进一步的骨转移,内脏转移,从癌症诊断到发展的时间间隔。 MSCC,运动功能障碍的发展时间和非卧床状态。结果:在多变量分析中,发现东部合作肿瘤小组的表现状态,肿瘤类型,骨转移,内脏转移,从癌症诊断到转移性脊髓压迫发展的时间间隔,运动功能障碍发展的时间以及非卧床状态与生存率显着相关。风险评分代表每种因素评分的总和,取自患者在2个月内死亡的概率(显示为百分比)除以10。风险评分范围为6到25分。截断值为24分时,特异性为99.8%,阳性预测值为96.0%,这表明约有4%的预计在2个月内死亡的患者存活> 2个月。结论:该评分可鉴定出存活率极低,特异性高,阳性预测值高的患者。得分为24分的患者在2个月内死亡的可能性很高。因此,可以避免在这些患者中避免采用强化疗法的过度治疗,这些患者极不可能从中受益。Cancer2013。(c)2012 American Cancer Society。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号